LPCN
LipocineCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
11
U.S. public peers
Grade Position
In line
vs peer average
LPCN vs peer average
67/100
LPCN vs. peer average (C vs. D)
Grade spread
C 3 · D 4 · F 4
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
JSPR is the first available peer comparator.
Loose same-sector, similar-market-cap biotech peer; useful mainly for event-driven risk comparison, not a direct LPCN product analogue.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
LPCN
Lipocine
JSPR
Jasper Therapeutics
Grade
C
F
Momentum
100
61
Value
58
41
Sentiment
57
31
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs JSPR
LPCN / JSPR
Grade Position
In line
LPCN vs. peer average (C vs. D)
67/100
Momentum
100
LPCNValue
58
LPCNSentiment
57
LPCNRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs LPCN
JSPR is the first peer returned for this comparison set.